Medical Developments International Limited (ASX:MVP) insider Robert (Max) Johnston purchased 4,300 shares of the business’s stock in a transaction on Wednesday, June 2nd. The shares were bought at an average price of A$4.67 ($3.34) per share, with a total value of A$20,081.00 ($14,343.57).
Robert (Max) Johnston also recently made the following trade(s):
- On Thursday, May 13th, Robert (Max) Johnston purchased 5,517 shares of Medical Developments International stock. The shares were bought at an average price of A$5.30 ($3.79) per share, with a total value of A$29,240.10 ($20,885.79).
The company has a quick ratio of 3.39, a current ratio of 4.03 and a debt-to-equity ratio of 4.85.
Medical Developments International Limited manufactures and distributes pharmaceutical and veterinary products, and medical devices. The company operates through three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management for use in home or in hospitals; Penthrox, a prescription only medicine for pain relief; medical devices; and various veterinary anesthetic machines to veterinarians.
Featured Article: Back-End Load
Receive News & Ratings for Medical Developments International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Developments International and related companies with MarketBeat.com's FREE daily email newsletter.